Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Bioorganic & Medicinal Chemistry Letters
|
January 13, 2010
Spirocyclic ureas: orally bioavailable 11 beta-HSD1 inhibitors identified by computer-aided drug design
Colin M Tice, Wei Zhao, Zhenrong Xu, et al.
Bioorganic & Medicinal Chemistry
|
May 22, 2017
Discovery of BI 135585, an in vivo efficacious oxazinanone-based 11β hydroxysteroid dehydrogenase type 1 inhibitor
Linghang Zhuang, Colin M Tice, Zhenrong Xu, et al.
Journal of Medicinal Chemistry
|
July 27, 2011
Structure-based design and synthesis of 1,3-oxazinan-2-one inhibitors of 11β-hydroxysteroid dehydrogenase type 1
Zhenrong Xu, Colin M Tice, Wei Zhao, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 5, 2009
Optimization of orally bioavailable alkyl amine renin inhibitors
Zhenrong Xu, Salvacion Cacatian, Jing Yuan, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 25, 2010
Discovery and optimization of adamantyl carbamate inhibitors of 11β-HSD1
Colin M Tice, Wei Zhao, Paula M Krosky, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 8, 2016
Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core
Colin M Tice, Paul B Noto, Kristi Yi Fan, et al.
Journal of Medicinal Chemistry
|
March 19, 2016
Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR) β Agonist
Yajun Zheng, Linghang Zhuang, Kristi Yi Fan, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Bioorganic & Medicinal Chemistry Letters
|
January 13, 2010
Spirocyclic ureas: orally bioavailable 11 beta-HSD1 inhibitors identified by computer-aided drug design
Colin M Tice, Wei Zhao, Zhenrong Xu, et al.
Bioorganic & Medicinal Chemistry
|
May 22, 2017
Discovery of BI 135585, an in vivo efficacious oxazinanone-based 11β hydroxysteroid dehydrogenase type 1 inhibitor
Linghang Zhuang, Colin M Tice, Zhenrong Xu, et al.
Journal of Medicinal Chemistry
|
July 27, 2011
Structure-based design and synthesis of 1,3-oxazinan-2-one inhibitors of 11β-hydroxysteroid dehydrogenase type 1
Zhenrong Xu, Colin M Tice, Wei Zhao, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 5, 2009
Optimization of orally bioavailable alkyl amine renin inhibitors
Zhenrong Xu, Salvacion Cacatian, Jing Yuan, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 25, 2010
Discovery and optimization of adamantyl carbamate inhibitors of 11β-HSD1
Colin M Tice, Wei Zhao, Paula M Krosky, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 8, 2016
Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core
Colin M Tice, Paul B Noto, Kristi Yi Fan, et al.
Journal of Medicinal Chemistry
|
March 19, 2016
Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR) β Agonist
Yajun Zheng, Linghang Zhuang, Kristi Yi Fan, et al.
Page
of 3